Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors

医学 泛秃 斑秃 免疫检查点 皮肤病科 粘膜皮肤区 免疫学 免疫系统 白癜风 免疫疗法 内科学 疾病
作者
Allison J. Zarbo,Viswanath Reddy Belum,Vincent Sibaud,Stéphane Marie. Oudard,Michael Andrew Postow,Jia‐Juan Hsieh,Robert John Motzer,Klaus Johannes BUSAM,Mario E. Lacouture
出处
期刊:British Journal of Dermatology [Oxford University Press]
卷期号:176 (6): 1649-1652 被引量:113
标识
DOI:10.1111/bjd.15237
摘要

Cytotoxic T-lymphocyte-associated protein-4, programmed cell death protein and programmed cell death protein ligand 1 monoclonal antibodies (immune checkpoint inhibitors), are used to treat various malignancies. Their mechanism of action involves the inhibition of negative regulators of immune activation, resulting in immune-related adverse events (irAEs) including endocrinopathies, pneumonitis, colitis, hepatitis and dermatological events. Dermatological irAEs include maculopapular rash, pruritus, vitiligo, blistering disorders, mucocutaneous lichenoid eruptions, rosacea and the exacerbation of psoriasis. Alopecia secondary to immune checkpoint inhibitors has been reported in 1·0-2·0% of treated patients. Our objective is to characterize for the first time the clinicopathology of patients with alopecia areata (AA) secondary to immune checkpoint inhibitors, including the first report of anti-PD-L1 therapy-induced AA, and review of the literature. Four cases of patients who developed partial or complete alopecia during treatment with immune checkpoint inhibitors for underlying cancer were identified from our clinics. Methods include the review of the history and clinicopathologic features. Three patients (75%) had AA and one had universalis. Two patients had a resolution after topical, oral or intralesional therapies and one had a resolution after immunotherapy was discontinued; all regrown hair exhibited poliosis. One of the four patients had coincident onychodystrophy. This report describes a series of four patients who developed partial or complete alopecia (i.e. areata and universalis) during treatment with immune checkpoint inhibitor therapies for cancer. The recognition and management of hair-related irAEs are important for pretherapy counselling and interventions that contribute to maintaining optimal health-related quality of life in patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
田様的应助被科研通管家采纳,获得10
1秒前
ding的应助被科研通管家采纳,获得10
1秒前
科研通AI65的应助被科研通管家采纳,获得10
1秒前
传奇3的应助被科研通管家采纳,获得10
1秒前
1秒前
luyue9406的应助被科研通管家采纳,获得10
1秒前
霁月发布了新的文献求助10
1秒前
天天快乐的应助被科研通管家采纳,获得10
1秒前
霁月发布了新的文献求助10
1秒前
霁月发布了新的文献求助10
2秒前
Lucas的应助被科研通管家采纳,获得30
2秒前
科研通AI65的应助被科研通管家采纳,获得10
2秒前
李爱国的应助被xy采纳,获得10
2秒前
Youdge的应助被科研通管家采纳,获得20
2秒前
Youdge的应助被科研通管家采纳,获得20
2秒前
天天快乐的应助被科研通管家采纳,获得10
2秒前
SciGPT的应助被科研通管家采纳,获得10
2秒前
Akim的应助被科研通管家采纳,获得10
2秒前
3秒前
科目三的应助被科研通管家采纳,获得10
3秒前
3秒前
糖果悠悠的应助被小红采纳,获得10
3秒前
情怀的应助被科研通管家采纳,获得10
3秒前
Feng的应助被科研通管家采纳,获得20
3秒前
李爱国的应助被科研通管家采纳,获得10
3秒前
共享精神的应助被科研通管家采纳,获得10
3秒前
Lucas的应助被科研通管家采纳,获得10
3秒前
充电宝的应助被科研通管家采纳,获得10
3秒前
烟花的应助被科研通管家采纳,获得10
4秒前
十万毫升硫酸钡完成签到 ,获得积分10
4秒前
852的应助被科研通管家采纳,获得10
4秒前
Youdge的应助被科研通管家采纳,获得10
4秒前
Youdge的应助被科研通管家采纳,获得20
4秒前
繁荣的瑛的应助被科研通管家采纳,获得10
4秒前
小二郎的应助被科研通管家采纳,获得10
4秒前
bkagyin的应助被科研通管家采纳,获得10
4秒前
斯文败类的应助被科研通管家采纳,获得10
4秒前
2799完成签到,获得积分10
5秒前
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8187328
求助须知:如何正确求助?哪些是违规求助? 9575427
关于积分的说明 21841244
捐赠科研通 7784994
什么是DOI,文献DOI怎么找? 3434935
关于科研通互助平台的介绍 2559375
邀请新用户注册赠送积分活动 2481820